Raymond James & Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,373
| Closed | -$221K | – | 4073 |
|
|
2022
Q1 | $221K | Sell |
6,373
-562
| -8% | -$19.5K | ﹤0.01% | 3581 |
|
|
2021
Q4 | $203K | Sell |
6,935
-7,235
| -51% | -$212K | ﹤0.01% | 3664 |
|
|
2021
Q3 | $361K | Buy |
14,170
+6,150
| +77% | +$157K | ﹤0.01% | 3273 |
|
|
2021
Q2 | $281K | Sell |
8,020
-1,782
| -18% | -$62.4K | ﹤0.01% | 3456 |
|
|
2021
Q1 | $399K | Sell |
9,802
-1,420
| -13% | -$57.8K | ﹤0.01% | 3151 |
|
|
2020
Q4 | $486K | Sell |
11,222
-1,538
| -12% | -$66.6K | ﹤0.01% | 2812 |
|
|
2020
Q3 | $704K | Sell |
12,760
-6,886
| -35% | -$380K | ﹤0.01% | 2392 |
|
|
2020
Q2 | $1.24M | Buy |
19,646
+2,728
| +16% | +$172K | ﹤0.01% | 2010 |
|
|
2020
Q1 | $864K | Sell |
16,918
-4,845
| -22% | -$247K | ﹤0.01% | 2076 |
|
|
2019
Q4 | $1.73M | Buy |
21,763
+4,338
| +25% | +$345K | ﹤0.01% | 1907 |
|
|
2019
Q3 | $845K | Buy |
17,425
+8,211
| +89% | +$398K | ﹤0.01% | 2284 |
|
|
2019
Q2 | $485K | Buy |
+9,214
| New | +$485K | ﹤0.01% | 2681 |
|